mp.weixin.qq.com·· 2 days agoPickScore60
Ivonescimab Plus Chemotherapy for First-Line Biliary Tract Cancer Proposed for CDE Priority Review
In brief
A new indication for ivonescimab, filed by Akeso/Summit (Kangfang Sainuo), combining ivonescimab with chemotherapy as first-line treatment for locally advanced or metastatic biliary tract cancer, has been proposed for priority review by the CDE. The information appeared on the CDE website on October 23, 2026. Biliary tract cancer is usually diagnosed late with poor prognosis; patients with advanced disease have a survival rate of only 2-3%.
Why it matters
The material gives the regulatory development of priority review for ivonescimab's biliary tract cancer indication and 2-3% survival context.
Source: mp.weixin.qq.com · mp.weixin.qq.com